Literature DB >> 10085050

Vaccinated mice remain more susceptible to Mycobacterium tuberculosis infection initiated via the respiratory route than via the intravenous route.

R J North1, R LaCourse, L Ryan.   

Abstract

Mice given Mycobacterium tuberculosis bacilli via the respiratory route succumbed much sooner to infection than mice given 1,000 times more bacilli via the intravenous route. Vaccination provided increased protection to an M. tuberculosis challenge infection; however, mice infected via the respiratory route remained much more susceptible.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10085050      PMCID： PMC96560          DOI： 10.1128/IAI.67.4.2010-2012.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  10 in total

Review 1.  T cells and cytokines in intracellular bacterial infections: experiences with Mycobacterium bovis BCG.

Authors:  S H Kaufmann; C H Ladel; I E Flesch
Journal:  Ciba Found Symp       Date:  1995

Review 2.  The role of T-cell subsets in Mycobacterium tuberculosis infection.

Authors:  W H Boom
Journal:  Infect Agents Dis       Date:  1996-03

3.  The influence of vaccination on the course of experimental airborne tuberculosis in mice.

Authors:  R F Schell; W F Ealey; G E Harding; D W Smith
Journal:  J Reticuloendothel Soc       Date:  1974-09

Review 4.  Protective effect of BCG in experimental tuberculosis.

Authors:  D W Smith
Journal:  Adv Tuberc Res       Date:  1985

5.  Host-parasite relationships in experimental airborne tuberculosis. IV. Early events in the course of infection in vaccinated and nonvaccinated guinea pigs.

Authors:  D W Smith; D N McMurray; E H Wiegeshaus; A A Grover; G E Harding
Journal:  Am Rev Respir Dis       Date:  1970-12

6.  Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.

Authors:  K Huygen; J Content; O Denis; D L Montgomery; A M Yawman; R R Deck; C M DeWitt; I M Orme; S Baldwin; C D'Souza; A Drowart; E Lozes; P Vandenbussche; J P Van Vooren; M A Liu; J B Ulmer
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

7.  Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route.

Authors:  R J North
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

8.  Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice.

Authors:  P L Dunn; R J North
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Persistent infection with virulent but not avirulent Mycobacterium tuberculosis in the lungs of mice causes progressive pathology.

Authors:  P L Dunn; R J North
Journal:  J Med Microbiol       Date:  1996-08       Impact factor: 2.472

Review 10.  T cell response to Mycobacterium tuberculosis.

Authors:  I M Orme; P Andersen; W H Boom
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226
  10 in total
  13 in total

1.  Anamnestic responses of mice following Mycobacterium tuberculosis infection.

Authors:  Arati B Kamath; Samuel M Behar
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Novel conjugate of moxifloxacin and carboxymethylated glucan with enhanced activity against Mycobacterium tuberculosis.

Authors:  Y S Schwartz; M I Dushkin; V A Vavilin; E V Melnikova; O M Khoschenko; V A Kozlov; A P Agafonov; A Y Alekseev; Y Rassadkin; A M Shestapalov; M S Azaev; D V Saraev; P N Filimonov; Y Kurunov; A V Svistelnik; V A Krasnov; A Pathak; S C Derrick; R C Reynolds; S Morris; V M Blinov
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells.

Authors:  Bruno Rivas-Santiago; Stephan K Schwander; Carmen Sarabia; Gill Diamond; Marcia E Klein-Patel; Rogelio Hernandez-Pando; Jerrold J Ellner; Eduardo Sada
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Inoculation route-dependent and allergen-specific suppressive effects of bacille Calmette-Guérin vaccination on asthmatic reactions in BALB/c mice.

Authors:  Inseon S Choi; Xiang-Hua Lin; Young-Ah Koh; Yong Cui
Journal:  Lung       Date:  2007-04-04       Impact factor: 2.584

Review 5.  Innate immunity to Mycobacterium tuberculosis.

Authors:  Reinout van Crevel; Tom H M Ottenhoff; Jos W M van der Meer
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

6.  Infection of mice with aerosolized Mycobacterium tuberculosis: use of a nose-only apparatus for delivery of low doses of inocula and design of an ultrasafe facility.

Authors:  J Reid Schwebach; Bing Chen; Aharona Glatman-Freedman; Arturo Casadevall; John D McKinney; John L Harb; Patrick J McGuire; W Emmett Barkley; Barry R Bloom; William R Jacobs
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

7.  Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis.

Authors:  Antonia Isabel Castillo-Rodal; Mauricio Castañón-Arreola; Rogelio Hernández-Pando; Juan José Calva; Eduardo Sada-Díaz; Yolanda López-Vidal
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

8.  Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity.

Authors:  Alissa A Chackerian; Jennifer M Alt; Thushara V Perera; Christopher C Dascher; Samuel M Behar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 9.  Early T-cell responses in tuberculosis immunity.

Authors:  Gary M Winslow; Andrea Cooper; William Reiley; Madhumouli Chatterjee; David L Woodland
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

10.  Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model.

Authors:  Gopinath S Palanisamy; Erin E Smith; Crystal A Shanley; Diane J Ordway; Ian M Orme; Randall J Basaraba
Journal:  Tuberculosis (Edinb)       Date:  2008-03-05       Impact factor: 3.131
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.